NanoVibronix, Inc. (CIK: 0001326706) EDGAR, Information, Filings... CompaniesBIO.Com

NanoVibronix, Inc.

Mailing address
525 EXECUTIVE BLVD, ELMSFORD, Delaware, 10523
Phone
(914) 233-3004
State location
New York
State of incorporation
Delaware
Fiscal year end
December 31
SIC
3842 - (CF Office: Office of Life Sciences) ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Filings
N/A

NanoVibronix, Inc. (CIK: 0001326706) is an American company incorporated in the state of New York. Head office is located at 525 EXECUTIVE BLVD, ELMSFORD, New York, 10523. Work in the industry 3842 - (CF Office: Office of Life Sciences) ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES. NanoVibronix, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Nano Vibronix, Inc. from 2011-06-Dec to 2014-25-Mar
Nano Vibronix Inc from 2005-05-May to 2005-05-May

Owner	Filings	Transaction Date	Type of Owner
Cassirer Aurora	0001905696	Jan-13-2022	director
Schroeder Maria	0001906106	Jan-13-2022	director
FASHEK CHRISTOPHER M	0001279063	Oct-14-2016	director
Murphy Brian M	0001687795	Oct-13-2016	director, officer: Chief Executive Officer
MIKA THOMAS	0001263576	Apr-27-2015	director
Ferguson Michael	0001607534	Apr-27-2015	director
GREENSTEIN IRA A	0001228161	Apr-10-2015	director
BROWN STEPHEN RUSSELL	0001246334	Apr-10-2015	officer: Chief Financial Officer
JACOB HAROLD	0001443692	Apr-10-2015	director, officer: Chief Medical Officer
Stern William	0001607801	Apr-10-2015	director, officer: Chief Executive Officer
Zumeris Jona	0001607803	Apr-10-2015	director, officer: VP of Technology
Goldstein Martin M	0001639061	Apr-10-2015	director
Kelly Miriam W	0001639279	Apr-10-2015	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NanoVibronix, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001493152-24-047385 (34 Act) Size: KB	Nov-22-2024	001-36445 241489995
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-24-005329 (34 Act) Size: KB	Nov-14-2024	005-89369 241464334
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-24-045726 (34 Act) Size: KB	Nov-14-2024	001-36445 241460821
ARS	Document	Annual report to security holders Acc-no: 0001493152-24-042900 (34 Act) Size: KB	Oct-29-2024	001-36445 241406138
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001493152-24-042895 (34 Act) Size: KB	Oct-29-2024	001-36445 241406101
DEF 14A	Document	Definitive proxy statements Acc-no: 0001493152-24-042890 (34 Act) Size: KB	Oct-29-2024	001-36445 241405987
8-K	Document	Current report filing Acc-no: 0001493152-24-040934 (34 Act) Size: KB	Oct-11-2024	001-36445 241368047
8-K	Document	Current report filing Acc-no: 0001493152-24-040311 (34 Act) Size: KB	Oct-07-2024	001-36445 241358371
8-K	Document	Current report filing Acc-no: 0001493152-24-038139 (34 Act) Size: KB	Sep-25-2024	001-36445 241325332
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-24-032138 (34 Act) Size: KB	Aug-14-2024	001-36445 241207190
8-K	Document	Current report filing Acc-no: 0001493152-24-020229 (34 Act) Size: KB	May-16-2024	001-36445 24955493
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-24-019675 (34 Act) Size: KB	May-15-2024	001-36445 24949004
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-24-016463 (34 Act) Size: KB	Apr-26-2024	001-36445 24883532
8-K	Document	Current report filing Acc-no: 0001493152-24-014611 (34 Act) Size: KB	Apr-15-2024	001-36445 24844678
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-24-014096 (34 Act) Size: KB	Apr-09-2024	001-36445 24833541
8-K	Document	Current report filing Acc-no: 0001493152-24-014067 (34 Act) Size: KB	Apr-09-2024	001-36445 24832729
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-24-013966 (34 Act) Size: KB	Apr-08-2024	001-36445 24830583
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001493152-24-012408 (34 Act) Size: KB	Apr-01-2024	001-36445 24809845
8-K	Document	Current report filing Acc-no: 0001493152-24-011629 (34 Act) Size: KB	Mar-28-2024	001-36445 24793910
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001493152-24-007898 ( Act) Size: 0 KB	Feb-26-2024

Recent 20 filings. View all NanoVibronix, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

NanoVibronix, Inc. overview
NanoVibronix, Inc. job
NanoVibronix, Inc. stock
NanoVibronix, Inc. ownership
NanoVibronix, Inc. CEO
NanoVibronix, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.